EFFICACY OF THE COMPLEMENT INHIBITOR ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS NEVER TRANSFUSED

被引：0
|
作者：
Risitano, A. [1 ]
Alfinito, F. [1 ]
Seneca, E. [1 ]
Marando, L. [1 ]
Boschetti, C. [2 ]
Bonfigli, S. [3 ]
Fenu, S. [4 ]
Re, F. [5 ]
Gosetti, G. [6 ]
Khursigara, G.
Rother, R.
Zanella, A. [2 ]
Rotoli, B. [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Osped Policlin Maggiore, IRCCS, Milan, Italy
[3] Univ Sassari, I-07100 Sassari, Italy
[4] S Giovanni Addolorata Hosp, Rome, Italy
[5] Univ Parma, I-43100 Parma, Italy
[6] Santa Chiara Hosp, Trento, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0581
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [41] Erythropoietin treatment during complement inhibition with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria
    Hill, A.
    Richards, S. J.
    Rother, R. P.
    Hillmen, P.
    [J]. HAEMATOLOGICA, 2007, 92 (03) : E31 - E33
  • [42] A CASE OF CHILDHOOD PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA: SAFETY AND EFFICACY OF THE TERMINAL COMPLEMENT INHIBITOR ECULIZUMAB
    La Barba, G.
    Sau, A.
    Pulini, S.
    Passeri, C.
    Salutari, P.
    Melatti, G.
    Risitano, A. M.
    Fioritoni, G.
    [J]. HAEMATOLOGICA, 2008, 93 : S60 - S60
  • [43] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
    Rodriguez-Garcia, Juan
    Fernandez-Santos, Rafael
    Antonio Garcia-Erce, Jose
    [J]. MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
  • [44] Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria
    Schubert, Joerg
    Hillmen, Peter
    Roeth, Alexander
    Young, Neal S.
    Elebute, Modupe O.
    Szer, Jeffery
    Gianfaldoni, Giacomo
    Socie, Gerard
    Browne, Paul
    Geller, Robert
    Rother, Russel P.
    Muus, Petra
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (02) : 263 - 272
  • [45] The terminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal haemoglobinuria
    Hillmen, P.
    Hill, A.
    Muus, P.
    Duhrsen, U.
    Risitano, A. M.
    Schubert, J.
    Young, N. S.
    Schrezenmeier, H.
    Szer, J.
    Brodsky, R. A.
    Socie, G.
    Rollins, S. A.
    Rother, R. P.
    Bell, L.
    Luzzatto, L.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 34 - 34
  • [46] Antiphospholipid antibodies in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
    Helley, D.
    Darnige, L.
    de Latour, R. P.
    Zemori, L.
    Socie, G.
    Fischer, A-M
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 624 - 624
  • [47] Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria
    Seregina, E. A.
    Tsvetaeva, N. V.
    Nikulina, O. F.
    Zapariy, A. P.
    Erasov, A. V.
    Gribkova, I. V.
    Orel, E. B.
    Ataullakhanov, F. I.
    Balandina, A. N.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (02) : 144 - 150
  • [48] Achievements and Limitations of Complement Inhibition by Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: The Role of Complement Component 3
    Risitano, A. M.
    Perna, F.
    Selleri, C.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 528 - 535
  • [49] Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria
    Zareba, Karolina M.
    [J]. DRUGS OF TODAY, 2007, 43 (08) : 539 - 546
  • [50] Eculizumab in paroxysmal nocturnal hemoglobinuria - The author replies
    Hillmen, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26): : 2787 - 2788
12345